Literature DB >> 30391291

Can the N170 Be Used as an Electrophysiological Biomarker Indexing Face Processing Difficulties in Autism Spectrum Disorder?

Sofie Vettori1, Corentin Jacques2, Bart Boets1, Bruno Rossion3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30391291     DOI： 10.1016/j.bpsc.2018.07.015

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN： 2451-9022


× No keyword cloud information.
  6 in total

1.  The Unfulfilled Promise of the N170 as a Social Biomarker.

Authors:  Alexandra P Key; Blythe A Corbett
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-09-13

2.  Refining biomarker evaluation in ASD.

Authors:  James C McPartland
Journal:  Eur Neuropsychopharmacol       Date:  2021-04-29       Impact factor: 5.415

3.  Reduced neural sensitivity to rapid individual face discrimination in autism spectrum disorder.

Authors:  Sofie Vettori; Milena Dzhelyova; Stephanie Van der Donck; Corentin Jacques; Jean Steyaert; Bruno Rossion; Bart Boets
Journal:  Neuroimage Clin       Date:  2018-11-28       Impact factor: 4.881

4.  Fast Periodic Visual Stimulation EEG Reveals Reduced Neural Sensitivity to Fearful Faces in Children with Autism.

Authors:  Stephanie Van der Donck; Milena Dzhelyova; Sofie Vettori; Hella Thielen; Jean Steyaert; Bruno Rossion; Bart Boets
Journal:  J Autism Dev Disord       Date:  2019-11

Review 5.  Facial Expression Processing Across the Autism-Psychosis Spectra: A Review of Neural Findings and Associations With Adverse Childhood Events.

Authors:  Celine Samaey; Stephanie Van der Donck; Ruud van Winkel; Bart Boets
Journal:  Front Psychiatry       Date:  2020-11-13       Impact factor: 4.157

6.  Frequency-Tagging Electroencephalography of Superimposed Social and Non-Social Visual Stimulation Streams Reveals Reduced Saliency of Faces in Autism Spectrum Disorder.

Authors:  Sofie Vettori; Milena Dzhelyova; Stephanie Van der Donck; Corentin Jacques; Jean Steyaert; Bruno Rossion; Bart Boets
Journal:  Front Psychiatry       Date:  2020-04-28       Impact factor: 4.157
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.